Arachidonic Acid Metabolism and Tumor Promotion by Susan M. Fischer (English) Pa

Description: Arachidonic Acid Metabolism and Tumor Promotion by Susan M. Fischer, Thomas J. Slaga Prostaglandins, Leukotrienes, and Cancer is a multi-volume series that will focus on an emerging area of cancer research. In 1968, R.H. Williams first reported that elevated prostaglandin levels are present in human medullary carÂ cinoma. Since that time, the concept that arachidonic acid metabolites may be inÂ volved in cancer has expanded to include every aspect of the disease from cell transformation through metastasis. Prostaglandins and leukotrienes are generic terms used to describe a family of bioactive lipids produced from unsaturated fatty acids (principally from and lipoxygenase pathways, respecÂ arachidonic acid) via the cyclooxygenase tively. Cyclooxygenase products consist of diverse products such as prostaÂ glandin E2 (POE), prostacyclin (POI) and thromboxane A2 (TXA), whereas 2 2 2 lipoxygenase products consist of hydroperoxy fatty acids and mono-, di- and tri-hydroxy acids including leukotrienes. The precursor fatty acids for the cyclooxygenase and lipoxygenase pathways are present in cellular phospholipids. This finding established an important control point in their biosynthesis-the release of substrate. This occurs in response to numerous stimuli that act at the cell surface. Dr. Bengt Samuelssons extensive study of the metabolism of prosÂ taglandins indicated that they are rapidly inactivated on a single pass through pulmonary circulation. Thus, they cannot act as circulating hormones and appear to be made on demand in or in the vicinity of target tissues leading to the concept that prostaglandins are local hormones or autoc FORMAT Paperback LANGUAGE English CONDITION Brand New Publisher Description Prostaglandins, Leukotrienes, and Cancer is a multi-volume series that will focus on an emerging area of cancer research. In 1968, R.H. Williams first reported that elevated prostaglandin levels are present in human medullary car- cinoma. Since that time, the concept that arachidonic acid metabolites may be in- volved in cancer has expanded to include every aspect of the disease from cell transformation through metastasis. Prostaglandins and leukotrienes are generic terms used to describe a family of bioactive lipids produced from unsaturated fatty acids (principally from and lipoxygenase pathways, respec- arachidonic acid) via the cyclooxygenase tively. Cyclooxygenase products consist of diverse products such as prosta- glandin E2 (POE), prostacyclin (POI) and thromboxane A2 (TXA), whereas 2 2 2 lipoxygenase products consist of hydroperoxy fatty acids and mono-, di- and tri-hydroxy acids including leukotrienes. The precursor fatty acids for the cyclooxygenase and lipoxygenase pathways are present in cellular phospholipids. This finding established an important control point in their biosynthesis-the release of substrate.This occurs in response to numerous stimuli that act at the cell surface. Dr. Bengt Samuelssons extensive study of the metabolism of pros- taglandins indicated that they are rapidly inactivated on a single pass through pulmonary circulation. Thus, they cannot act as circulating hormones and appear to be made on demand in or in the vicinity of target tissues leading to the concept that prostaglandins are local hormones or autocoids. Table of Contents 1. Arachidonic Acid Metabolism in the Skin.- 2. Arachidonic Acid Metabolism and Tumor Promotion.- 3. Prostaglandins, Epidermal Hyperplasia and Skin Tumor Promotion.- 4. Effects of Phorbol Esters on Phospholipid Metabolism in Vitro.- 5. Tumor Promoting Phorbol Esters May Affect Cell Membrane Signal Transmission by Protein Kinase.- 6. Active Oxygen and Promotion.- 7. Possible Involvement of Arachidonate Products in Tumor Promoter Inhibition of Cell-Cell Communication.- 8. Proteases and Cyclic Nucleotides.- Perspectives. Promotional Springer Book Archives Long Description Prostaglandins, Leukotrienes, and Cancer is a multi-volume series that will focus on an emerging area of cancer research. In 1968, R.H. Williams first reported that elevated prostaglandin levels are present in human medullary car Details ISBN1461296315 Short Title ARACHIDONIC ACID METABOLISM & Pages 264 Series Prostaglandins, Leukotrienes, and Cancer Language English ISBN-10 1461296315 ISBN-13 9781461296317 Media Book Format Paperback DEWEY 572 Series Number 3 Imprint Springer-Verlag New York Inc. Country of Publication United States Year 2011 Publication Date 2011-09-27 Edited by Thomas J. Slaga Place of Publication New York, NY DOI 10.1007/978-1-4613-2605-2 UK Release Date 2011-09-27 AU Release Date 2011-09-27 NZ Release Date 2011-09-27 US Release Date 2011-09-27 Author Thomas J. Slaga Illustrations VIII, 264 p. Publisher Springer-Verlag New York Inc. Edition Description Softcover reprint of the original 1st ed. 1985 Alternative 9780898387247 Audience Professional & Vocational We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! TheNile_Item_ID:96347835;

Price: 314.31 AUD

Location: Melbourne

End Time: 2025-01-14T17:39:39.000Z

Shipping Cost: 9.49 AUD